Carlsbad and Santa Clara, CA 2/5/08—Invitrogen and Agilent have reached a confidential agreement to settle three lawsuits. Stratagene, which Agilent acquired last year (see IBO 4/15/07), was a party in all three suits. Under the agreement, Agilent will make a payment to Invitrogen for an undisclosed amount and discontinue sales of RNase H minus reverse […]
Invitrogen and HUPO (the Human Proteome Organization) launched the HUPO Gold Mass Spectrometry Protein Standard sampling program for development of what Invitrogen calls “the first commercially available all-recombinant human protein standard for mass spectrometry.” Applied Biosystems introduced the Cliquid Drug Screen and Quant Software for Routine Forensic Toxicology, a new software application for its LC/MS/MS […]
President Bush’s proposed budget, released February 4, for fiscal year 2009 calls for a 3.3% increase in the federal R&D investment to $145.4 billion. Federal support of basic and applied R&D would drop 0.5% to $57.1 billion, with a 3.1% increase in basic research spending to $29.3 billion and a 4.0% decrease in applied research […]
: In January, the World Bank’s Board of Executive Directors approved a $13.4 million loan for Kazakhstan’s Technology Commercialization Project (TCP). The TCP has a total budget of $75 million, $61.6 million of which comes from Kazakhstan’s government, and seeks to restore some of the country’s scientific capacity, which was strong during the Soviet era. […]
Carlsbad, CA 2/15/08—Invitrogen has acquired a minority equity share in Q Therapeutics, a company developing cell therapeutic indications for the central nervous system (CNS) by purifying, culturing and growing populations of differentiated CNS cells for injection into patients.
Affymetrix awarded premier application status to Beckman Coulter’s ArrayPlex application for automated target RNA preparation on the Biomek 3000. Platicell entered into an agreement with Hamilton to automate its Combinatorial Cell Culture technology for determining optimal protocols to direct stem cell differentiation. Tecan AG and pION launched the PAMPA (Parallel Artificial Membrane Permeability Assay) Explorer […]
The Chilean Economic Development Agency (CORFO) estimates that $100 million will be spent on R&D in the country during 2008 through InnovaChile, CORFO’s innovation department. If private industry meets government investment, total R&D funding could reach $200 million this year. The majority of funding will go to clusters recommended by the National Council of Innovation […]
Fluxion Biosciences appointed AutoMate Scientific as a distributor of its BioFlux System. Amaxa and Promega will develop applications based on their respective Nucleofector technology and luciferase reporter assay technologies to monitor cell signaling events in cells that are difficult to transfect. Roche Applied Sciences will exclusively market systems for real-time cell analysis based on ACEA […]
Velocity11 launched the Automated Microplate Spin-down Station for 320 microplates, which integrates the BenchCel Microplate Handling System and the Vspin Access 2 Microplate Centrifuge. CyBio AG introduced the CyBi-DiluSpro 8-channel pipettor for volumes of 0.5 µL–250 µL, the CyBi-Well vario multichannel pipettor for volumes of 25 nL–250 µL and the CyBi-RoboSpense all-purpose pipetting robot. Eppendorf […]
The FDA approved 17 new molecular entities (NMEs) and two biological license applications in 2007, the lowest number of new approvals since 2002. Nine of the 19 approvals were the subject of priority review status, which is given to a drug for which few available treatments exist. Four of the new approvals were for oncology […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
